Some studies have suggested that Alzheimer’s disease biomarker levels may differ by race. Now, researchers led by John Morris and Suzanne Schindler, Washington University, St. Louis, offer a genetic ...
GENT, Belgium--(BUSINESS WIRE)--Fujirebio Europe today announced the commercial launch of two new cerebrospinal fluid (CSF) based immunoassays for the novel neurology biomarkers NPTX2 and sTREM2 on ...
Loss-of-function mutations in the microglial protein TREM2 increase a person's risk for late-onset Alzheimer’s. Could boosting TREM2 expression protect against AD, even in those genetically destined ...
GENT, Belgium & MALVERN, Pa. & TOKYO, June 04, 2025--(BUSINESS WIRE)--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 ...
Microglia-mediated neuroinflammation is strongly implicated in the pathogenesis of Alzheimer disease (AD), but its timing in relation to the amyloid cascade has been unclear. Using a soluble form of ...
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated LUMIPULSE® G immunoassay analyzers. This ...
(MENAFN- AETOSWire) (BUSINESS WIRE )--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G sTREM2 assay for the fully automated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback